{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:32:11Z","timestamp":1788960731102,"version":"build-2803163510"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11686-025-01128-6","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:21:48Z","timestamp":1757420508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Human African Trypanosomiasis (HAT): Epidemiology, Biological Diagnosis and Treatment: A Review"],"prefix":"10.1007","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9014-7908","authenticated-orcid":false,"given":"Patindoilba Marcel","family":"Sawadogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Axel T.","family":"Kabore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiswendsida Thierry","family":"Guiguemde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adama","family":"Zida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"12","key":"1128_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000906","volume":"4","author":"LM MacLean","year":"2010","unstructured":"MacLean LM, Odiit M, Chisi JE, Kennedy PGE, Sternberg JM (2010) Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 4(12):e906","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1128_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0035-9203(69)90075-3","volume":"63","author":"JR Baker","year":"1969","unstructured":"Baker JR, McConnell E (1969) Human trypanosomiasis in Ethiopia. Trans R Soc Trop Med Hyg 63(1):114","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"1128_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3201\/eid2307.170695","volume":"23","author":"A Luintel","year":"2017","unstructured":"Luintel A, Lowe P, Cooper A, MacLeod A, B\u00fcscher P, Brooks T et al (2017) Case of Nigeria-acquired human African trypanosomiasis in United Kingdom, 2016. Emerg Infect Dis 23(7):1225\u20131227","journal-title":"Emerg Infect Dis"},{"issue":"31\u201332","key":"1128_CR4","first-page":"1203","volume":"114","author":"T L\u00f6scher","year":"1989","unstructured":"L\u00f6scher T, Nothdurft HD, Taelman H, Boogaerts M, Omar M, von Sonnenburg F (1989) Sleeping sickness in German travelers to the tropics. Dtsch Med Wochenschr 114(31\u201332):1203\u20131206","journal-title":"Dtsch Med Wochenschr"},{"issue":"6 Pt B","key":"1128_CR5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.tmaid.2014.09.010","volume":"12","author":"D Malvy","year":"2014","unstructured":"Malvy D, Khatibi S, Rivi\u00e8re B, Prudhomme L, Ezzedine K (2014) Challenging issues and pitfalls for diagnosis of Human African trypanosomiasis in a Gabonese visitor, France. Travel Med Infect Dis 12(6 Pt B):778\u2013780","journal-title":"Travel Med Infect Dis"},{"issue":"9213","key":"1128_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(00)02141-3","volume":"355","author":"C Burri","year":"2000","unstructured":"Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun R (2000) Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial. Lancet 355(9213):1419\u20131425","journal-title":"Lancet"},{"issue":"4","key":"1128_CR7","first-page":"140","volume":"19","author":"J Chisi","year":"2007","unstructured":"Chisi J, Nkhoma A, Sternberg J (2007) Presentation of trypanosomiasis in nkhotakota. Malawi Med J 19(4):140\u2013141","journal-title":"Malawi Med J"},{"key":"1128_CR8","unstructured":"Jamot E (1933) Contribution \u00e0 l\u2019\u00e9tude de la maladie du sommeil en Afrique Occidentale Fran\u00e7aise (Ouagadougou). Doc Tech OCCGE. p 492"},{"issue":"3","key":"1128_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/0035-9203(65)90002-7","volume":"59","author":"P Richet","year":"1965","unstructured":"Richet P (1965) L\u2019histoire et l\u2019oeuvre de L\u2019O.C.C.G.E. en afrique occidentale francophone. Trans R Soc Trop Med Hyg 59(3):234\u2013251","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"1128_CR10","first-page":"132","volume":"22","author":"B Bernard","year":"2008","unstructured":"Bernard B (2008) La maladie du sommeil de Jamot \u00e0 nos jours ou l\u2019histoire de la lutte contre ce fl\u00e9au. The sleeping sickness combat story from the Jamot\u2019s period until. Riv Parassitol 22(1):132\u2013139","journal-title":"Riv Parassitol"},{"issue":"4","key":"1128_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1051\/parasite\/2012194389","volume":"19","author":"R Kambir\u00e9","year":"2012","unstructured":"Kambir\u00e9 R, Lingu\u00e9 K, Courtin F, Sidib\u00e9 I, Kiendr\u00e9b\u00e9ogo D, N\u2019gouan KE, bl\u00e9 L, Kaba D, Koffi M, Solano P, Bucheton B, Jamonneau V (2012) La trypanosomose humaine africaine dans l\u2019espace ivoiro-burkinab\u00e9\u202f: optimisation des strat\u00e9gies de surveillance \u00e9pid\u00e9miologique. Parasite 19(4):389\u2013396","journal-title":"Parasite"},{"key":"1128_CR12","first-page":"41","volume":"430","author":"H Talabani","year":"2011","unstructured":"Talabani H, Ancelle T (2011) Le diagnostic de la trypanosomose humaine africaine. Rev Francoph Lab 430:41\u201346","journal-title":"Rev Francoph Lab"},{"issue":"1","key":"1128_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3166\/bspe-2018-0002","volume":"111","author":"Y Andjingbopou","year":"2018","unstructured":"Andjingbopou Y, Lenga A, Nzoumbou-Boko R, Bitsindou P, Douzima PM, Mbelesso P (2018) Situation \u00e9pid\u00e9miologique de la trypanosomose humaine africaine dans la commune de Bilolo en R\u00e9publique centrafricaine. Bull Soc Pathol Exot 111(1):12","journal-title":"Bull Soc Pathol Exot"},{"key":"1128_CR14","first-page":"257","volume":"6","author":"JR Franco","year":"2014","unstructured":"Franco JR, Simarro PP, Diarra A, Jannin JG (2014) Epidemiology of human African trypanosomiasis. Clin Epidemiol 6:257\u2013275","journal-title":"Clin Epidemiol"},{"issue":"2","key":"1128_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/0972-9062.310860","volume":"57","author":"KU Ozioko","year":"2020","unstructured":"Ozioko KU, Okoye CI, Obiezue RN, Idika IK, Awudu RA, Ezewudo BI, Ezea CO (2020) Accelerating towards human African trypanosomiasis elimination: Issues and opportunities. J Vector Borne Dis 57(2):105\u2013113","journal-title":"J Vector Borne Dis"},{"issue":"01","key":"1128_CR16","first-page":"53422","volume":"12","author":"MB Somda","year":"2022","unstructured":"Somda MB, Karambiri SM, Kabore J, Dama E, Compaore CFA (2022) Perceptions et pratiques de gestion de la maladie du sommeil des communaut\u00e9s vivant \u00e0 proximit\u00e9 des sites aurif\u00e8res au sud-ouest du Burkina Faso. Int J Dev Res. 12(01):53422\u201353427","journal-title":"Int J Dev Res."},{"key":"1128_CR17","first-page":"215","volume":"71","author":"J Jannin","year":"1993","unstructured":"Jannin J, Moulia-Pelat JP, Chanfrea B, Penchenier L, Louis JP, Nzaba P et al (1993) Trypanosomiase humaine africaine Etude d\u2019un score de pr\u00e9somption de diagnostic au Congo. Bull World Health Organ 71:215\u2013222","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1128_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13104-020-05077-3","volume":"13","author":"BW Kulohoma","year":"2020","unstructured":"Kulohoma BW, Wamwenje SAO, Wangwe II, Masila N, Mirieri CK, Wambua L (2020) Prevalence of trypanosomes associated with drug resistance in Shimba Hills, Kwale County, Kenya. BMC Res Notes 13(1):234","journal-title":"BMC Res Notes"},{"issue":"1","key":"1128_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/tropicalmed5010014","volume":"5","author":"H De Koning","year":"2020","unstructured":"De Koning H (2020) The drugs of sleeping sickness: their mechanisms of action and resistance, and a brief history. Trop Med Infect Dis 5(1):14","journal-title":"Trop Med Infect Dis"},{"issue":"1","key":"1128_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-3156.2003.01152.x","volume":"9","author":"PM Abel","year":"2004","unstructured":"Abel PM, Kiala G, L\u00f4a V, Behrend M, Musolf J, Fleischmann H et al (2004) Retaking sleeping sickness control in Angola. Trop Med Int Health 9(1):141\u2013148","journal-title":"Trop Med Int Health"},{"issue":"6","key":"1128_CR21","first-page":"257","volume":"6","author":"JR Franco","year":"2014","unstructured":"Franco JR, Simarro PP, Diarra A, Jannin JG (2014) Epidemiology of human African trypanosomiasis. Clin Epidemiol 6(6):257\u2013275","journal-title":"Clin Epidemiol"},{"issue":"8","key":"1128_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001246","volume":"5","author":"D Mumba","year":"2011","unstructured":"Mumba D, Bohorquez E, Messina J, Kande V, Taylor SM, Tshefu AK et al (2011) Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis 5(8):e1246","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"1128_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010036","volume":"15","author":"BM Traor\u00e9","year":"2021","unstructured":"Traor\u00e9 BM, Koffi M, N\u2019Djetchi MK, Kaba D, Kabor\u00e9 J, Ilboudo H et al (2021) Free-ranging pigs identified as a multi-reservoir of Trypanosoma brucei and Trypanosoma congolense in the Vavoua area, a historical sleeping sickness focus of C\u00f4te d\u2019Ivoire. PLoS Negl Trop Dis 15(12):e0010036","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"1128_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006677","volume":"12","author":"E Dama","year":"2018","unstructured":"Dama E, Drabo A, Kabor\u00e9 J, Ou\u00e9draogo E, Coulibaly B, Ilboudo H et al (2018) Description of the first sleeping sickness case diagnosed in Burkina Faso since two decades. PLoS Negl Trop Dis 12(8):e0006677","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1128_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007283","volume":"13","author":"C Fowler","year":"2019","unstructured":"Fowler C, MacLeod A, Matovu E, Simo G (2019) Association between IL1 gene polymorphism and human African trypanosomiasis in populations of sleeping sickness foci of southern Cameroon. PLoS Negl Trop Dis 13(3):e0007283","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1128_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006504","volume":"12","author":"LM Kazumba","year":"2018","unstructured":"Kazumba LM, Kaka J-CT, Ngoyi DM, Tshala-Katumbay D (2018) Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis\u202f: a critical appraisal of 23 years of experience in the Democratic Republic of Congo. PLoS Negl Trop Dis 12(6):e0006504","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"1128_CR27","first-page":"523","volume":"38","author":"G Binz","year":"1968","unstructured":"Binz G, Timperman G, Hutchinson MP (1968) Estimation of serum immunoglobulin M as a screening technique for trypanosomiasis. A field trial in the Democratic Republic of the Congo. Bull World Health Organ 38(4):523\u2013545","journal-title":"Bull World Health Organ"},{"issue":"12","key":"1128_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1046\/j.1365-3156.1999.00494.x","volume":"4","author":"PP Simarro","year":"1999","unstructured":"Simarro PP, Ruiz JA, Franco JR, Josenando T (1999) Attitude towards CATT-positive individuals without parasitological confirmation in the African Trypanosomiasis (T. b. gambiense) focus of Qui\u00e7ama (Angola). Trop Med Int Health 4(12):858\u2013861","journal-title":"Trop Med Int Health"},{"issue":"1","key":"1128_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000590","volume":"4","author":"V Lejon","year":"2010","unstructured":"Lejon V, Ngoyi DM, Boelaert M, B\u00fcscher P (2010) A CATT negative result after treatment for human African trypanosomiasis is no indication for cure. PLoS Negl Trop Dis 4(1):e590","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1128_CR30","first-page":"882","volume":"80","author":"P Truc","year":"2002","unstructured":"Truc P, Lejon V, Magnus E, Jamonneau V, Nangouma A, Verloo D et al (2002) Evaluation of the micro-CATT, CATT\/Trypanosoma brucei gambiense, and LATEX\/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa. Bull World Health Organ 80(11):882\u2013886","journal-title":"Bull World Health Organ"},{"issue":"2","key":"1128_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0001-706X(00)00095-4","volume":"76","author":"V Jamonneau","year":"2000","unstructured":"Jamonneau V, Truc P, Garcia A, Magnus E, B\u00fcscher P (2000) Preliminary evaluation of LATEX\/T. b. gambiense and alternative versions of CATT\/T. b. gambiense for the serodiagnosis of human African trypanosomiasis of a population at risk in C\u00f4te d\u2019Ivoire: considerations for mass-screening. Acta Trop 76(2):175\u2013183","journal-title":"Acta Trop"},{"issue":"7556","key":"1128_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bmj.38859.531354.7C","volume":"332","author":"WO Inojosa","year":"2006","unstructured":"Inojosa WO, Augusto I, Bisoffi Z, Josenado T, Abel PM, Stich A et al (2006) Diagnosing human African trypanosomiasis in Angola using a card agglutination test\u202f: observational study of active and passive case finding strategies. BMJ 332(7556):1479","journal-title":"BMJ"},{"issue":"5","key":"1128_CR33","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0035-9203(97)90023-7","volume":"91","author":"VM Nantulya","year":"1997","unstructured":"Nantulya VM (1997) Tryptect CIATT\u2013a card indirect agglutination trypanosomiasis test for diagnosis of Trypanosoma brucei gambiense and T. b. rhodesiense infections. Trans R Soc Trop Med Hyg 91(5):551\u2013553. https:\/\/doi.org\/10.1016\/s0035-9203(97)90023-7","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"1128_CR34","first-page":"38","volume":"76","author":"MN Akol","year":"1999","unstructured":"Akol MN, Olaho-Mukani W, Odiit M, Enyaru JC, Matovu E, Magona J, Okitoi ND (1999) Trypanosomosis agglutination card test for Trypanosoma brucei rhodesiense sleeping sickness. East Afr Med J 76(1):38\u201341","journal-title":"East Afr Med J"},{"key":"1128_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1051\/parasite\/2022024","volume":"29","author":"CFA Compaor\u00e9","year":"2022","unstructured":"Compaor\u00e9 CFA, Kabor\u00e9 J, Ilboudo H, Thomas LF, Falzon LC, Bamba M et al (2022) Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Bati\u00e9, South-West Burkina Faso. Parasite 29:25. https:\/\/doi.org\/10.1051\/parasite\/2022024","journal-title":"Parasite"},{"issue":"7","key":"1128_CR36","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/tmi.12316","volume":"19","author":"O Camara","year":"2014","unstructured":"Camara O, Camara M, Lejon V, Ilboudo H, Sakande H, L\u00e9no M et al (2014) Immune trypanolysis test with blood spotted on filter paper for epidemiological surveillance of sleeping sickness. Trop Med Int Health 19(7):828\u2013831","journal-title":"Trop Med Int Health"},{"issue":"12","key":"1128_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000917","volume":"4","author":"V Jamonneau","year":"2010","unstructured":"Jamonneau V, Bucheton B, Kabor\u00e9 J, Ilboudo H, Camara O, Courtin F et al (2010) Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa. PLoS Negl Trop Dis 4(12):e917","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"1128_CR38","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3201\/eid2708.202399","volume":"27","author":"R Snijders","year":"2021","unstructured":"Snijders R, Fukinsia A, Claeys Y, Hasker E, Mpanya A, Miaka E et al (2021) Costs and outcomes of integrated human African trypanosomiasis surveillance system using rapid diagnostic tests, Democratic Republic of the Congo. Emerg Infect Dis 27(8):2144\u20132153","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"1128_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003373","volume":"8","author":"JM Sternberg","year":"2014","unstructured":"Sternberg JM, Gierli\u0144ski M, Bi\u00e9ler S, Ferguson MA, Ndung\u2019u JM (2014) Evaluation of the diagnostic accuracy of prototype rapid tests for human African trypanosomiasis. PLoS Negl Trop Dis 8(12):e3373","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1128_CR40","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1016\/S2214-109X(14)70203-7","volume":"2","author":"P B\u00fcscher","year":"2014","unstructured":"B\u00fcscher P, Mertens P, Leclipteux T, Gilleman Q, Jacquet D, Mumba-Ngoyi D et al (2014) Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. Lancet Glob Health 2(6):e359\u2013e363","journal-title":"Lancet Glob Health"},{"issue":"8","key":"1128_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009656","volume":"15","author":"M Kon\u00e9","year":"2021","unstructured":"Kon\u00e9 M, Kaba D, Kabor\u00e9 J, Thomas LF, Falzon LC, Koffi M, Kouam\u00e9 CM et al (2021) Passive surveillance of human African trypanosomiasis in C\u00f4te d\u2019Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. PLoS Negl Trop Dis 15(8):e0009656","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1128_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006386","volume":"12","author":"C Lumbala","year":"2018","unstructured":"Lumbala C, Bi\u00e9ler S, Kayembe S, Makabuza J, Ongarello S, Ndung\u2019u JM (2018) Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens. PLoS Negl Trop Dis 12(3):e0006386","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1128_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40249-018-0472-x","volume":"7","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Palmer JJ (2018) Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda\u2019s human African trypanosomiasis elimination programme. Infect Dis Poverty 7(1):84","journal-title":"Infect Dis Poverty"},{"issue":"7","key":"1128_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180555","volume":"12","author":"C Lumbala","year":"2017","unstructured":"Lumbala C, Bessell PR, Lutumba P, Baloji S, Bi\u00e9ler S, Ndung\u2019u JM (2017) Performance of the SD BIOLINE\u00ae HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo. PLoS ONE 12(7):e0180555","journal-title":"PLoS ONE"},{"issue":"4","key":"1128_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004608","volume":"10","author":"S Bisser","year":"2016","unstructured":"Bisser S, Lumbala C, Nguertoum E, Kande V, Flevaud L, Vatunga G et al (2016) Sensitivity and specificity of a prototype rapid diagnostic test for the detection of Trypanosoma brucei gambiense Infection: a multi-centric prospective study. PLoS Negl Trop Dis 10(4):e0004608","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1128_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003480","volume":"9","author":"V Jamonneau","year":"2015","unstructured":"Jamonneau V, Camara O, Ilboudo H, Peylhard M, Koffi M, Sakande H et al (2015) Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa. PLoS Negl Trop Dis 9(2):e0003480","journal-title":"PLoS Negl Trop Dis"},{"key":"1128_CR47","doi-asserted-by":"publisher","unstructured":"Layba CM, Kagbadouno M, Kourouma A, Diallo MB, Soumah AM, Camara O et al. (2025) Traitement oral de la trypanosomiase humaine africaine : faisabilit\u00e9 dans les communaut\u00e9s du littoral Guin\u00e9en. Sante Publique. 37(2):173\u2013184. French. https:\/\/doi.org\/10.3917\/spub.252.0173. 12(1):22","DOI":"10.3917\/spub.252.0173"},{"issue":"8","key":"1128_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012436","volume":"18","author":"AM Soumah","year":"2024","unstructured":"Soumah AM, Camara M, Kabor\u00e9 JW, Sadissou I, Ilboudo H, Travaill\u00e9 C et al (2024) Prevalence of dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis in Guinea. PLoS Negl Trop Dis 18(8):e0012436","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1128_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-018-0472-x","volume":"7","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Palmer JJ (2018) Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda\u2019s human African trypanosomiasis elimination programme. Infect Dis Poverty 7(1):84. https:\/\/doi.org\/10.1186\/s40249-018-0472-x","journal-title":"Infect Dis Poverty"},{"key":"1128_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-023-01076-1","author":"O Camara","year":"2023","unstructured":"Camara O, Camara M, Falzon LC, Ilboudo H, Kabor\u00e9 J, Compaor\u00e9 CFA et al (2023) Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study. Infect Dis Poverty. https:\/\/doi.org\/10.1186\/s40249-023-01076-1.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"1128_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0399-077X(78)80047-X","volume":"8","author":"J Roffi","year":"1978","unstructured":"Roffi J, Derouin F, Diallo PB (1978) Application d\u2019une m\u00e9thode immunoenzymatique (E.L.I.S.A.) au d\u00e9pistage de la trypanosomiase humaine africaine \u00e0 Trypanosoma brucei gambiense. Med Mal Infect 8(1):9\u201314","journal-title":"Med Mal Infect"},{"issue":"2","key":"1128_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/diagnostics12020246","volume":"12","author":"R Inocencio da Luz","year":"2022","unstructured":"Inocencio da Luz R, Tablado Alonso S, B\u00fcscher P, Verl\u00e9 P, De Weggheleire A, Mumba Ngoyi D et al (2022) Two-year follow-up of Trypanosoma brucei gambiense serology after successful treatment of human African trypanosomiasis: results of four different sero-diagnostic tests. Diagnostics (Basel) 12(2):246","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"1128_CR53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4269\/ajtmh.2010.09-0735","volume":"83","author":"E Hasker","year":"2010","unstructured":"Hasker E, Lutumba P, Mumba D, Lejon V, B\u00fcscher P, Kande V et al (2010) Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis. Am J Trop Med Hyg 83(2):374\u2013379","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"1128_CR54","doi-asserted-by":"publisher","first-page":"e0009407","DOI":"10.1371\/journal.pntd.0009407","volume":"15","author":"R Inocencio da Luz","year":"2021","unstructured":"Inocencio da Luz R, Phanzu DM, Kiabanzawoko ON, Miaka E, Verl\u00e9 P, De Weggheleire A et al (2021) Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis 15(6):e0009407","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1128_CR55","first-page":"714","volume":"67","author":"MB Somda","year":"2022","unstructured":"Somda MB, Kabor\u00e9 J, Karambiri SM, Dama E, Dabir\u00e9 D, Compaor\u00e9 CFA et al (2022) Evaluation of the re-emergence risk of human African Trypanosomiasis in the southwestern Burkina Faso. A Gold-Bearing Mutation Area Acta Parasitol 67(2):714\u2013722","journal-title":"A Gold-Bearing Mutation Area Acta Parasitol"},{"issue":"5","key":"1128_CR56","doi-asserted-by":"publisher","first-page":"652","DOI":"10.4269\/ajtmh.1992.47.652","volume":"47","author":"JA Nicolas","year":"1992","unstructured":"Nicolas JA, Dumas M (1992) Human African trypanosomiasis: presence of antibodies to galactocerebrosides. Am J Trop Med Hyg 47(5):652\u2013662","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"1128_CR57","first-page":"513","volume":"38","author":"G Duvallet","year":"1978","unstructured":"Duvallet G, Saliou P, Rey JL (1978) Fiabilite de la reaction d\u2019immunofluorescence indirecte pour le diagnostic de la trypanosomiase humaine africaine [Reliability of the indirect immunofluorescence test in the diagnosis of African human trypanosomiasis (author\u2019s transl)]. Med Trop (Mars). 38(5):513\u2013517","journal-title":"Med Trop (Mars)."},{"issue":"5","key":"1128_CR58","first-page":"527","volume":"39","author":"M Mangenot","year":"1979","unstructured":"Mangenot M, Chaize J, Desfontaine M, Duvallet G, Moreau JP (1979) Int\u00e9ret de la technique ELISA pour le d\u00e9pistage dans les foyers de trypanosomiase humaine africaine. Comparaison avec l\u2019immunofluorescence [Comparative value of ELISA technique and immunofluorescence for the detection in the foci of human African trypanosomiasis]. Med Trop (Mars). 39(5):527\u2013530","journal-title":"Med Trop (Mars)."},{"issue":"1","key":"1128_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.18.1.133-146.2005","volume":"18","author":"F Chappuis","year":"2005","unstructured":"Chappuis F, Loutan L, Simarro P, Lejon V, B\u00fcscher P (2005) Options for Field Diagnosis of Human African Trypanosomiasis. Clin Microbiol Rev janv 18(1):133\u2013146","journal-title":"Clin Microbiol Rev janv"},{"issue":"2","key":"1128_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0035-9203(88)90430-0","volume":"82","author":"F Noireau","year":"1988","unstructured":"Noireau F, Lemesre JL, Nzoukoudi MY, Louembet MT, Gouteux JP, Frezil JL (1988) Serodiagnosis of sleeping sickness in the Republic of the Congo: comparison of indirect immunofluorescent antibody test and card agglutination test. Trans R Soc Trop Med Hyg 82(2):237\u2013240","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"1128_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007051","volume":"13","author":"V Lejon","year":"2019","unstructured":"Lejon V, B\u00fcscher P, Nzoumbou-Boko R, Bossard G, Jamonneau V, Bucheton B, Truc P, Lemesre JL, Solano P, Vincendeau P (2019) The separation of trypanosomes from blood by anion exchange chromatography: from Sheila Lanham\u2019s discovery 50 years ago to a gold standard for sleeping sickness diagnosis. PLoS Negl Trop Dis 13(2):e0007051","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1128_CR62","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-3156.2004.01240.x","volume":"9","author":"J Robays","year":"2004","unstructured":"Robays J, Bilengue MM, Van der Stuyft P, Boelaert M (2004) The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health 9(5):542\u2013550","journal-title":"Trop Med Int Health"},{"issue":"3","key":"1128_CR63","first-page":"245","volume":"57","author":"T Ancelle","year":"1997","unstructured":"Ancelle T, Paugam A, Bourlioux F, Merad A, Vigier JP (1997) D\u00e9tection des trypanosomes dans le sang par la technique du Quantitative Buffy Coat (QBC): \u00e9valuation exp\u00e9rimentale [Detection of trypanosomes in blood by the Quantitative Buffy Coat (QBC) technique: experimental evaluation]. Med Trop (Mars) 57(3):245\u2013248","journal-title":"Med Trop (Mars)"},{"issue":"6","key":"1128_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002954","volume":"8","author":"D Mumba Ngoyi","year":"2014","unstructured":"Mumba Ngoyi D, Ali Ekangu R, Mumvemba Kodi MF, Pyana PP, Balharbi F, Decq M et al (2014) Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sickness. PLoS Negl Trop Dis 8(6):e2954","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1128_CR65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0035-9203(79)90092-0","volume":"73","author":"WH Lumsden","year":"1979","unstructured":"Lumsden WH, Kimber CD, Evans DA, Doig SJ (1979) Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use. Trans R Soc Trop Med Hyg 73(3):312\u2013317","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"1128_CR66","first-page":"101","volume":"87","author":"TW Miezan","year":"1994","unstructured":"Miezan TW, Meda AH, Doua F, Cattand P (1994) Evaluation des techniques parasitologiques utilis\u00e9es dans le diagnostic de la trypanosomose humaine a Trypanosoma gambiense en C\u00f4te-d\u2019Ivoire [Evaluation of the parasitologic technics used in the diagnosis of human Trypanosoma gambiense trypanosomiasis in the Ivory Coast]. Bull Soc Pathol Exot 87(2):101\u2013104","journal-title":"Bull Soc Pathol Exot"},{"issue":"11","key":"1128_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000471","volume":"3","author":"P B\u00fcscher","year":"2009","unstructured":"B\u00fcscher P, Mumba Ngoyi D, Kabor\u00e9 J, Lejon V, Robays J, Jamonneau V et al (2009) Improved Models of mini anion exchange centrifugation technique (mAECT) and modified single centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 3(11):e471","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1128_CR68","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-3156.2010.02546.x","volume":"15","author":"M Camara","year":"2010","unstructured":"Camara M, Camara O, Ilboudo H, Sakande H, Kabor\u00e9 J, N\u2019Dri L et al (2010) Sleeping sickness diagnosis: use of buffy coats improves the sensitivity of the mini anion exchange centrifugation test. Trop Med Int Health 15(7):796\u2013799","journal-title":"Trop Med Int Health"},{"issue":"1","key":"1128_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cid\/ciaa897","volume":"73","author":"M Camara","year":"2021","unstructured":"Camara M, Soumah AM, Ilboudo H, Travaill\u00e9 C, Clucas C, Cooper A et al (2021) Extravascular dermal trypanosomes in suspected and confirmed cases of gambiense human African trypanosomiasis. Clin Infect Dis 73(1):12\u201320","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1128_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002504","volume":"7","author":"P Mitashi","year":"2013","unstructured":"Mitashi P, Hasker E, Ngoyi DM, Pyana PP, Lejon V, Van der Veken W et al (2013) Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples. PLoS Negl Trop Dis 7(10):e2504","journal-title":"PLoS Negl Trop Dis"},{"key":"1128_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2020.108014","volume":"219","author":"CF Alfred Compaor\u00e9","year":"2020","unstructured":"Alfred Compaor\u00e9 CF, Ilboudo H, Kabor\u00e9 J, Kabor\u00e9 JW, Camara O et al (2020) Analytical sensitivity of loopamp and quantitative real-time PCR on dried blood spots and their potential role in monitoring human African trypanosomiasis elimination. Exp Parasitol 219:108014","journal-title":"Exp Parasitol"},{"issue":"5","key":"1128_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1586\/14737159.2015.1027195","volume":"15","author":"P B\u00fcscher","year":"2015","unstructured":"B\u00fcscher P, Deborggraeve S (2015) How can molecular diagnostics contribute to the elimination of human African trypanosomiasis? Expert Rev Mol Diagn 15(5):607\u2013615","journal-title":"Expert Rev Mol Diagn"},{"issue":"16","key":"1128_CR73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2174\/1568026618666181025095735","volume":"18","author":"MA Dea-Ayuela","year":"2018","unstructured":"Dea-Ayuela MA, Galiana-Rosell\u00f3 C, Lalatsa A, Serrano DR (2018) Applying loop-mediated isothermal amplification (LAMP) in the diagnosis of malaria, leishmaniasis and trypanosomiasis as point-of-care tests (POCTs). Curr Top Med Chem 18(16):1358\u20131374","journal-title":"Curr Top Med Chem"},{"issue":"Pt 1","key":"1128_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0031182000061023","volume":"99","author":"DR Moser","year":"1989","unstructured":"Moser DR, Cook GA, Ochs DE, Bailey CP, McKane MR, Donelson JE (1989) Detection of Trypanosoma congolense and Trypanosoma brucei subspecies by DNA amplification using the polymerase chain reaction. Parasitology 99(Pt 1):57\u201366","journal-title":"Parasitology"},{"issue":"6","key":"1128_CR75","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4269\/ajtmh.2002.67.684","volume":"67","author":"M Radwanska","year":"2002","unstructured":"Radwanska M, Chamekh M, Vanhamme L, Claes F, Magez S, Magnus E et al (2002) The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense. Am J Trop Med Hyg 67(6):684\u2013690","journal-title":"Am J Trop Med Hyg"},{"key":"1128_CR76","first-page":"1","volume":"881","author":"World Health organisation","year":"1998","unstructured":"World Health organisation (1998) Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 881:1\u2013114","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"9","key":"1128_CR77","first-page":"745","volume":"77","author":"P Truc","year":"1999","unstructured":"Truc P, Jamonneau V, Cuny G, Fr\u00e9zil JL (1999) Use of polymerase chain reaction in human African trypanosomiasis stage determination and follow-up. Bull World Health Organ 77(9):745\u2013748","journal-title":"Bull World Health Organ"},{"issue":"7","key":"1128_CR78","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1365-3156.2010.02547.x","volume":"15","author":"CM Mugasa","year":"2010","unstructured":"Mugasa CM, Deborggraeve S, Schoone GJ, Laurent T, Leeflang MM, Ekangu RA et al (2010) Accordance and concordance of PCR and NASBA followed by oligochromatography for the molecular diagnosis of Trypanosoma brucei and Leishmania. Trop Med Int Health 15(7):800\u2013805","journal-title":"Trop Med Int Health"},{"issue":"8","key":"1128_CR79","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/JCM.02594-05","volume":"44","author":"S Deborggraeve","year":"2006","unstructured":"Deborggraeve S, Claes F, Laurent T, Mertens P, Leclipteux T, Dujardin JC, Herdewijn P, B\u00fcscher P (2006) Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol 44(8):2884\u20132889","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1128_CR80","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/JCM.01430-08","volume":"47","author":"CM Mugasa","year":"2009","unstructured":"Mugasa CM, Laurent T, Schoone GJ, Kager PA, Lubega GW, Schallig HD (2009) Nucleic acid sequence-based amplification with oligochromatography for detection of Trypanosoma brucei in clinical samples. J Clin Microbiol 47(3):630\u2013635","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1128_CR81","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/clinids\/23.4.847","volume":"23","author":"S Ponce-de- Le\u00f3n","year":"1996","unstructured":"Ponce-de-Le\u00f3n S, Lisker-Melman M, Kato-Maeda M, Gamboa-Dom\u00ednguez A, Ontiveros C, Behrens RH et al (1996) Trypanosoma brucei rhodesiense infection imported to Mexico from a tourist resort in Kenya. Clin Infect Dis 23(4):847\u2013848","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1128_CR82","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.trstmh.2006.12.001","volume":"101","author":"AM heckley","year":"2007","unstructured":"heckley AM, Pepin J, Gibson WC, Taylor MN, J\u00e4ger HR, Mabey DC (2007) Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy. Trans R Soc Trop Med Hyg 101(5):523\u2013526","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"1128_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050055","volume":"5","author":"PP Simarro","year":"2008","unstructured":"Simarro PP, Jannin J, Cattand P (2008) Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 5(2):e55","journal-title":"PLoS Med"},{"issue":"11","key":"1128_CR84","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1046\/j.1365-3156.2000.00623.x","volume":"5","author":"A Garcia","year":"2000","unstructured":"Garcia A, Jamonneau V, Magnus E, Laveissi\u00e8re C, Lejon V, N\u2019Guessan P et al (2000) Follow-up of Card Agglutination Test for Trypanosomiasis (CATT) positive but apparently aparasitaemic individuals in C\u00f4te d\u2019Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health 5(11):786\u2013793","journal-title":"Trop Med Int Health"},{"issue":"2","key":"1128_CR85","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.actatropica.2006.04.001","volume":"98","author":"M Koffi","year":"2006","unstructured":"Koffi M, Solano P, Denizot M, Courtin D, Garcia A, Lejon V, B\u00fcscher P et al (2006) Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop 98(2):183\u2013188","journal-title":"Acta Trop"},{"issue":"1","key":"1128_CR86","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0166-6851(01)00208-0","volume":"113","author":"M Berberof","year":"2001","unstructured":"Berberof M, P\u00e9rez-Morga D, Pays E (2000) A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense. Mol Biochem Parasitol 113(1):127\u2013138","journal-title":"Mol Biochem Parasitol"},{"issue":"3","key":"1128_CR87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4269\/ajtmh.2002.67.289","volume":"67","author":"M Radwanska","year":"2002","unstructured":"Radwanska M, Claes F, Magez S, Magnus E, Perez-Morga D, Pays E et al (2002) Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense. Am J Trop Med Hyg 67(3):289\u2013295","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"1128_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004363","volume":"10","author":"G Pohlig","year":"2016","unstructured":"Pohlig G, Bernhard SC, Blum J, Burri C, Mpanya A, Lubaki JP et al (2016) Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial. PLoS Negl Trop Dis 10(2):e0004363","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1128_CR89","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/00001432-200412000-00009","volume":"17","author":"J Jannin","year":"2004","unstructured":"Jannin J, Cattand P (2004) Treatment and control of human African trypanosomiasis. Curr Opin Infect Dis 17(6):565\u2013571","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"1128_CR90","doi-asserted-by":"publisher","first-page":"e02515","DOI":"10.1128\/AAC.02515-18","volume":"63","author":"JA Watson","year":"2019","unstructured":"Watson JA, Strub-Wourgraft N, Tarral A, Ribeiro I, Tarning J, White NJ (2019) Pharmacokinetic-pharmacodynamic assessment of the hepatic and bone marrow toxicities of the new trypanoside fexinidazole. Antimicrob Agents Chemother 63(4):e02515-e2518","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1128_CR91","doi-asserted-by":"publisher","first-page":"e0008028","DOI":"10.1371\/journal.pntd.0008028","volume":"14","author":"A Kuemmerle","year":"2020","unstructured":"Kuemmerle A, Schmid C, Kande V, Mutombo W, Ilunga M, Lumpungu I et al (2020) Prescription of concomitant medications in patients treated with nifurtimox eflornithine combination therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo. PLoS Negl Trop Dis 14(1):e0008028","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1128_CR92","doi-asserted-by":"publisher","first-page":"e0009903","DOI":"10.1371\/journal.pntd.0009903","volume":"15","author":"A Kuemmerle","year":"2021","unstructured":"Kuemmerle A, Schmid C, Bernhard S, Kande V, Mutombo W, Ilunga M et al (2021) Effectiveness of nifurtimox eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis 15(11):e0009903","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1128_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004362","volume":"10","author":"C Burri","year":"2016","unstructured":"Burri C, Yeramian PD, Allen JL, Merolle A, Serge KK, Mpanya A et al (2016) Efficacy, safety, and dose of pafuramidine, a new oral drug for treatment of first stage sleeping sickness, in a phase 2a clinical study and phase 2b randomized clinical studies. PLoS Negl Trop Dis 10(2):e0004362","journal-title":"PLoS Negl Trop Dis"},{"key":"1128_CR94","unstructured":"WHO: Guidelines for the treatment of human African trypanosomiasis (2023). https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo"},{"key":"1128_CR95","unstructured":"WHO: Guidelines for the treatment of human African trypanosomiasis (2024). https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/igo"},{"issue":"2","key":"1128_CR96","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","volume":"12","author":"PG Kennedy","year":"2013","unstructured":"Kennedy PG (2013) Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 12(2):186\u2013194","journal-title":"Lancet Neurol"},{"issue":"7","key":"1128_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071298","volume":"10","author":"A Venturelli","year":"2022","unstructured":"Venturelli A, Tagliazucchi L, Lima C, Venuti F, Malpezzi G, Magoulas GE et al (2022) Current treatments to control African trypanosomiasis and one health perspective. Microorganisms 10(7):1298","journal-title":"Microorganisms"},{"issue":"3","key":"1128_CR98","doi-asserted-by":"publisher","first-page":"e01168","DOI":"10.1128\/AAC.01168-19","volume":"64","author":"N Wiedemar","year":"2020","unstructured":"Wiedemar N, Hauser DA, M\u00e4ser P (2020) 100 years of suramin. Antimicrob Agents Chemother 64(3):e01168-e1219","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1128_CR99","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fimmu.2019.00039","volume":"25","author":"PGE Kennedy","year":"2019","unstructured":"Kennedy PGE, Rodgers J (2019) Clinical and neuropathogenetic aspects of human African trypanosomiasis. Front Immunol 25(10):39","journal-title":"Front Immunol"},{"issue":"6","key":"1128_CR100","doi-asserted-by":"publisher","first-page":"taab080","DOI":"10.1093\/jtm\/taab080","volume":"28","author":"PJJ Van Genderen","year":"2021","unstructured":"Van Genderen PJJ, Nouwen JL, De Mendon\u00e7a MM, Rijnders BJA, van Hellemond JJ (2021) Single-dose pentamidine substantially reduces viability of trypanosomes in human East African trypanosomiasis. J Travel Med 28(6):taab080","journal-title":"J Travel Med"},{"issue":"1\u20132","key":"1128_CR101","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2014.10.032","volume":"477","author":"B Cohrs","year":"2014","unstructured":"Cohrs B, Zhao Y, L\u00fctzen U, Culman J, Clement B, Zuhayra M (2014) In vivo SPECT imaging of [123I]-labeled pentamidine pro-drugs for the treatment of human African trypanosomiasis, pharmacokinetics, and bioavailability studies in rats. Int J Pharm 477(1\u20132):167\u2013175","journal-title":"Int J Pharm"},{"issue":"3","key":"1128_CR102","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","volume":"29","author":"N Baker","year":"2013","unstructured":"Baker N, de Koning HP, M\u00e4ser P, Horn D (2013) Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol 29(3):110\u2013118","journal-title":"Trends Parasitol"},{"issue":"6","key":"1128_CR103","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pt.2018.04.002","volume":"34","author":"AH Fairlamb","year":"2018","unstructured":"Fairlamb AH, Horn D (2018) Melarsoprol resistance in African trypanosomiasis. Trends Parasitol 34(6):481\u2013492","journal-title":"Trends Parasitol"},{"issue":"1","key":"1128_CR104","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","volume":"90","author":"AJ Nok","year":"2003","unstructured":"Nok AJ (2003) Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res 90(1):71\u201379","journal-title":"Parasitol Res"},{"issue":"5","key":"1128_CR105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","volume":"107","author":"P Babokhov","year":"2013","unstructured":"Babokhov P, Sanyaolu AO, Oyibo WA, Fagbenro-Beyioku AF, Iriemenam NC (2013) A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathog Glob Health 107(5):242\u2013252","journal-title":"Pathog Glob Health"},{"issue":"1","key":"1128_CR106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.idc.2018.10.003","volume":"33","author":"E Bottieau","year":"2019","unstructured":"Bottieau E, Clerinx J (2019) Human African trypanosomiasis: progress and stagnation. Infect Dis Clin North Am 33(1):61\u201377","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"1128_CR107","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1208\/s12248-022-00693-2","volume":"24","author":"C Amilon","year":"2022","unstructured":"Amilon C, Boberg M, Tarning J, \u00c4bel\u00f6 A, Ashton M, Jansson-L\u00f6fmark R (2022) Population pharmacodynamic modeling of eflornithine-based treatments against late-stage Gambiense human African trypanosomiasis and efficacy predictions of L-eflornithine-based therapy. AAPS J 24(3):48","journal-title":"AAPS J"},{"issue":"6","key":"1128_CR108","first-page":"CD006201","volume":"2013","author":"V Lutje","year":"2013","unstructured":"Lutje V, Seixas J, Kennedy A (2013) Chemotherapy for second-stage human African trypanosomiasis. Cochrane Database Syst Rev 2013(6):CD006201","journal-title":"Cochrane Database Syst Rev"},{"issue":"10116","key":"1128_CR109","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","volume":"391","author":"VKBK Mesu","year":"2018","unstructured":"Mesu VKBK, Kalonji WM, Bardonneau C, Mordt OV, Blesson S, Simon F et al (2018) Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet 391(10116):144\u2013154","journal-title":"Lancet"},{"issue":"11","key":"1128_CR110","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1358\/dot.2019.55.11.3068795","volume":"55","author":"AH Fairlamb","year":"2019","unstructured":"Fairlamb AH (2019) Fexinidazole for the treatment of human African trypanosomiasis. Drugs Today 55(11):705\u2013712","journal-title":"Drugs Today"},{"issue":"2","key":"1128_CR111","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/S1473-3099(19)30612-7","volume":"20","author":"AK Lindner","year":"2020","unstructured":"Lindner AK, Lejon V, Chappuis F, Seixas J, Kazumba L, Barrett MP et al (2020) New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice. Lancet Infect Dis 20(2):e38\u2013e46","journal-title":"Lancet Infect Dis"},{"key":"1128_CR112","first-page":"93","volume":"3","author":"JR Franco","year":"2012","unstructured":"Franco JR, Simarro PP, Diarra A, Ruiz-Postigo JA, Samo M, Jannin JG (2012) Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis. Res Rep Trop Med 3:93\u2013101","journal-title":"Res Rep Trop Med"},{"issue":"8","key":"1128_CR113","volume":"13","author":"J Hidalgo","year":"2021","unstructured":"Hidalgo J, Ortiz JF, Fabara SP, Eissa-Garc\u00e9s A, Reddy D, Collins KD et al (2021) Efficacy and toxicity of fexinidazole and nifurtimox plus eflornithine in the treatment of African trypanosomiasis: a systematic review. Cureus 13(8):e16881","journal-title":"Cureus"},{"issue":"7","key":"1128_CR114","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1016\/S2214-109X(21)00208-4","volume":"9","author":"V Kande Betu Ku Mesu","year":"2021","unstructured":"Kande Betu Ku Mesu V, Mutombo Kalonji W, Bardonneau C, Valverde Mordt O, Ngolo Tete D, Blesson S et al (2021) Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study. Lancet Glob Health 9(7):e999\u2013e1008","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1128_CR115","doi-asserted-by":"publisher","first-page":"e0015323","DOI":"10.1128\/cmr.00153-23","volume":"38","author":"MP Barrett","year":"2025","unstructured":"Barrett MP (2025) Transforming the chemotherapy of human African trypanosomiasis. Clin Microbiol Rev 38(1):e0015323","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"1128_CR116","doi-asserted-by":"publisher","first-page":"e0009939","DOI":"10.1371\/journal.pntd.0009939","volume":"15","author":"PC Steketee","year":"2021","unstructured":"Steketee PC, Giordani F, Vincent IM, Crouch K, Achcar F, Dickens NJ et al (2021) Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole. PLoS Negl Trop Dis 15(11):e0009939","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"1128_CR117","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2471\/blt.05.028399","volume":"84","author":"M Balasegaram","year":"2006","unstructured":"Balasegaram M, Harris S, Checchi F, Hamel C, Karunakara U (2006) Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ 84(10):777\u2013782. https:\/\/doi.org\/10.2471\/blt.05.028399","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1128_CR118","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/tropicalmed5010029","volume":"5","author":"EA Dickie","year":"2020","unstructured":"Dickie EA, Giordani F, Gould MK, M\u00e4ser P, Burri C, Mottram JC, Rao SPS, Barrett MP (2020) New drugs for human African trypanosomiasis: a twenty first century success story. Trop Med Infect Dis 5(1):29","journal-title":"Trop Med Infect Dis"},{"issue":"2","key":"1128_CR119","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.21429","volume":"64","author":"PG Kennedy","year":"2008","unstructured":"Kennedy PG (2008) The continuing problem of human African trypanosomiasis (sleeping sickness). Ann Neurol 64(2):116\u2013126","journal-title":"Ann Neurol"},{"issue":"5","key":"1128_CR120","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/0035-9203(91)90364-5","volume":"85","author":"U Bronner","year":"1991","unstructured":"Bronner U, Doua F, Ericsson O, Gustafsson LL, Mi\u00e9zan TW, Rais M et al (1991) Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in C\u00f4te d\u2019Ivoire. Trans R Soc Trop Med Hyg 85(5):608\u2013611","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"1128_CR121","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2125.1995.tb04451.x","volume":"39","author":"U Bronner","year":"1995","unstructured":"Bronner U, Gustafsson LL, Doua F, Ericsson O, Mi\u00e9zan T, Rais M, Rombo L (1995) Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness. Br J Clin Pharmacol 39(3):289\u2013295","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1128_CR122","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2869.1999.00160.x","volume":"8","author":"A Buguet","year":"1999","unstructured":"Buguet A, Tapie P, Bert J (1999) Reversal of the sleep\/wake cycle disorder of sleeping sickness after trypanosomicide treatment. J Sleep Res 8(3):225\u2013235","journal-title":"J Sleep Res"},{"issue":"10","key":"1128_CR123","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2471\/BLT.06.031955","volume":"84","author":"M Balasegaram","year":"2006","unstructured":"Balasegaram M, Harris S, Checchi F, Ghorashian S, Hamel C, Karunakara U (2006) Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull World Health Organ 84(10):783\u2013791","journal-title":"Bull World Health Organ"},{"issue":"8","key":"1128_CR124","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s13346-022-01127-4","volume":"12","author":"I Andreana","year":"2022","unstructured":"Andreana I, Bincoletto V, Milla P, Dosio F, Stella B, Arpicco S (2022) Nanotechnological approaches for pentamidine delivery. Drug Deliv Transl Res 12(8):1911\u20131927","journal-title":"Drug Deliv Transl Res"},{"issue":"5","key":"1128_CR125","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/clinids\/7.5.625","volume":"7","author":"M Sands","year":"1985","unstructured":"Sands M, Kron MA, Brown RB (1985) Pentamidine: a review. Rev Infect Dis 7(5):625\u2013634","journal-title":"Rev Infect Dis"},{"issue":"1","key":"1128_CR126","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28714","volume":"68","author":"S Sava\u015fan","year":"2021","unstructured":"Sava\u015fan S, George A, Sokolowski C, McGraw BJ, Rademacher H (2021) Aerodigestive adverse effects during intravenous pentamidine infusion for Pneumocystis jirovecii pneumonia prophylaxis. Pediatr Blood Cancer 68(1):e28714","journal-title":"Pediatr Blood Cancer"},{"key":"1128_CR127","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/cid\/cis886","volume":"56","author":"E Alirol","year":"2013","unstructured":"Alirol E, Schrumpf D, Heradi JA, Riedel A, de Patoul C, Quere M et al (2013) Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: m\u00e9decins sans fronti\u00e8res experience in the Democratic Republic of the Congo. Clin Infect Dis 56:195\u2013203","journal-title":"Clin Infect Dis"},{"issue":"15","key":"1128_CR128","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.4155\/fmc.13.162","volume":"5","author":"L Ferrins","year":"2013","unstructured":"Ferrins L, Rahmani R, Baell JB (2013) Drug discovery and human African trypanosomiasis: a disease less neglected? Future Med Chem 5(15):1801\u20131841","journal-title":"Future Med Chem"},{"issue":"5","key":"1128_CR129","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1046\/j.1365-3156.2001.00710.x","volume":"6","author":"J Blum","year":"2001","unstructured":"Blum J, Nkunku S, Burri C (2001) Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health 6(5):390\u2013400","journal-title":"Trop Med Int Health"},{"issue":"1","key":"1128_CR130","first-page":"57","volume":"70","author":"E Komba","year":"1992","unstructured":"Komba E, Odiit M, Mbulamberi DB, Chimfwembe EC, Nantulya VM (1992) Multicentre evaluation of an antigen-detection ELISA for the diagnosis of Trypanosoma brucei rhodesiense sleeping sickness. Bull World Health Organ 70(1):57\u201361","journal-title":"Bull World Health Organ"},{"issue":"7","key":"1128_CR131","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000737","volume":"4","author":"E Matovu","year":"2010","unstructured":"Matovu E, Mugasa CM, Ekangu RA, Deborggraeve S, Lubega GW, Laurent T et al (2010) Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda. PLoS Negl Trop Dis 4(7):e737","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1128_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/2001-1326-2-1","volume":"2","author":"N Tiberti","year":"2013","unstructured":"Tiberti N, Matovu E, Hainard A, Enyaru JC, Lejon V, Robin X et al (2013) New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients. Clin Transl Med 2(1):1. https:\/\/doi.org\/10.1186\/2001-1326-2-1","journal-title":"Clin Transl Med"},{"issue":"9","key":"1128_CR133","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/0959-8049(96)00139-6","volume":"32A","author":"NA Dawson","year":"1996","unstructured":"Dawson NA, Lush RM, Steinberg SM, Tompkins AC, Headlee DJ, Figg WD (1996) Suramin induced neutropenia. Eur J Cancer 32A(9):1534\u20131539","journal-title":"Eur J Cancer"},{"issue":"9","key":"1128_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.828111","volume":"7","author":"KI Kasozi","year":"2022","unstructured":"Kasozi KI, MacLeod ET, Ntulume I, Welburn SC (2022) An update on African trypanocide pharmaceutics and resistance. Front Vet Sci 7(9):828111","journal-title":"Front Vet Sci"},{"issue":"17","key":"1128_CR135","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/DDDT.S416325","volume":"11","author":"G Wu","year":"2023","unstructured":"Wu G, Zhou H, Lv D, Zheng R, Wu L, Yu S et al (2023) Phase I, single-dose study to assess the pharmacokinetics and safety of suramin in healthy Chinese volunteers. Drug Des Devel Ther 11(17):2051\u20132061","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"1128_CR136","first-page":"e47","volume":"23","author":"VK Betu Kumeso","year":"2023","unstructured":"Betu Kumeso VK, Kalonji WM, Rembry S, Valverde Mordt O, Ngolo Tete D, Pr\u00eatre A et al (2023) Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2\/3 trial. Lancet Infect Dis 23(2):e47","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1128_CR137","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S1473-3099(24)00581-4","volume":"25","author":"AK Lindner","year":"2025","unstructured":"Lindner AK, Lejon V, Barrett MP, Blumberg L, Bukachi SA, Chancey RJ et al (2025) New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine. Lancet Infect Dis 25(2):e77\u2013e85. https:\/\/doi.org\/10.1016\/S1473-3099(24)00581-4","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1128_CR138","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40265-019-1051-6","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks ED (2019) Fexinidazole: first global approval. Drugs 79(2):215\u2013220","journal-title":"Drugs"},{"issue":"4","key":"1128_CR139","first-page":"90","volume":"10","author":"S Bernhard","year":"2022","unstructured":"Bernhard S, Kaiser M, Burri C, M\u00e4ser P (2022) Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership. Dis 10(4):90","journal-title":"Dis"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-01128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-025-01128-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-025-01128-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:07:19Z","timestamp":1762420039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-025-01128-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":139,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1128"],"URL":"https:\/\/doi.org\/10.1007\/s11686-025-01128-6","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"193"}}